减少婴儿洗澡频率与强度的随机对照可行性试验
该随机对照可行性试验纳入105名有特应性家族史的孕妇,1:1随机分入干预组(婴儿6月龄内洗澡不超过每周一次且缩短时间、水温不宜过高、清水即可)或对照组(常规护理建议)。干预依从性高(80% vs 29%每周≤1次),6月龄可见湿疹干预组16% vs 对照组29%,无显著不良事件,支持开展更大规模试验。
要点
- 减少洗澡频率与强度在孕妇中随机分组可行,依从性高且可接受。
- 6月龄可见湿疹干预组16%(6/38)低于对照组29%(14/48)。
- 未报告干预相关值得关注的不良反应。
核心结论
- 在有特应性家族史的婴儿中,孕期随机分组至减少洗澡频率与强度的干预是可行的。
- 6月龄湿疹结局在干预组低于对照组,但本研究为可行性试验,不用于疗效推断。
研究设计与样本
- 随机对照可行性试验,105名有特应性家族史的孕妇按1:1随机分为干预组(n=52)和对照组(n=53)。
- 随机化在孕期或婴儿首次洗澡前进行,主要可行性结局为符合条件家庭愿意被随机化的比例。
- 次要临床结局为6月龄时采用英国工作组特应性皮炎诊断标准改编版进行盲法婴儿湿疹评估。
主要发现
- 筛查261名孕妇,排除21名不合格,纳入240名中105名(43.8%)被随机化。
- 干预组80%(35/44)看护者每周洗澡≤1次,对照组29%(14/49)。
- 干预组95%(38/40)看护者同意或非常同意干预可接受,对照组污染仅1/46。
- 88.6%(93/105)家庭完成6月龄问卷,81.9%(86/105)参加最终访视。
- 6月龄可见湿疹干预组16%(6/38)vs 对照组29%(14/48);家长报告湿疹9%(4/44)vs 12%(6/49);医生诊断的家长报告湿疹9%(3/44)vs 10%(5/49)。
关键数值与推荐
- 干预组要求婴儿6月龄内洗澡不超过每周一次,并保持洗澡时间短、水温不过高、通常清水清洗即可。
- 对照组接受产科常规婴儿护理建议。
- 湿疹评估采用英国工作组特应性皮炎诊断标准改编版进行盲法评估。
临床怎么用
- 对于有特应性家族史的婴儿家庭,可告知减少洗澡频率与强度(每周≤1次、短时、温水、清水)是可行且可接受的。
- 该干预未报告值得关注的不良反应,可作为预防湿疹的潜在可行策略进行进一步研究。
局限性
- 本研究为可行性试验,样本量小,不能据此确定干预对湿疹的预防效果。
- 湿疹结局为次要结局且部分基于家长报告,需更大规模试验验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bathing, even in tap water, alters skin physiology. Frequent infant bathing may increase the risk of eczema developing. OBJECTIVES: To undertake a randomized controlled feasibility trial of an intervention to reduce infant bathing frequency and intensity. METHODS: In total, 105 pregnant women (aged ≥ 16 years) with a family history of atopy and carrying a healthy singleton fetus (54 male, 51 female) were randomized in a 1 : 1 ratio during pregnancy or postnatally prior to their infant's first bath. Caregivers in the intervention group were asked to reduce how often they bathed their infants (no more than once a week for the first 6 months of age) and to reduce the intensity of the bathing (keeping baths short, ensuring the water was not too hot and washing in 'plain' water being usually sufficient). The control group received the routine postnatal infant care advice offered by their maternity unit. The primary feasibility outcome was the proportion of eligible families willing to be randomized to the intervention. The secondary clinical outcome was a blinded assessment of infant eczema at 6 months of age, using an adaptation of the UK Working Party Diagnostic Criteria for Atopic Dermatitis. The trial was registered with the ISRCTN Registry on 24 July 2023 (ISRCTN51491794). RESULTS: Altogether, 261 pregnant women were screened, of whom 21 were ineligible. Of the 240 women included, 105 (43.8%) were randomized to the intervention (n = 52) and control (n = 53) groups. Adherence to the intervention was high, with 80% (n = 35/44) of caregivers in the intervention arm bathing their infant once a week or less compared with 29% (n = 14/49) in the control group. In the intervention group, 95% (n = 38/40) of caregivers agreed or strongly agreed that the intervention was acceptable. There was minimal contamination of the control group as a result of awareness of the trial's purpose and accessing the intervention (n = 1/46). Follow-up was high, with 88.6% (n = 93/105) of families completing the final 6-month questionnaire and 81.9% (n = 86/105) attending the final visit. Eczema outcomes occurred less frequently in the intervention arm compared with the control arm, respectively: visible eczema 16% (n = 6/38) vs. 29% (n = 14/48); parent-reported eczema 9% (n = 4/44) vs. 12% (n = 6/49); and doctor-diagnosed parent-reported eczema 9% (n = 3/44) vs. 10% (n = 5/49). No noteworthy adverse effects of the intervention were reported. CONCLUSIONS: These findings support the feasibility of randomizing infants during pregnancy to a reduced frequency and intensity bathing intervention for eczema prevention. Eczema is a common inflammatory skin condition. We know that bathing, even in normal tap water, can alter the skin’s natural barrier. Previous research has suggested that frequently bathing infants may increase the risk of eczema. The risk may be particularly increased in children whose family has a history of allergies or related conditions. This is known as ‘atopy’. We carried out a test trial, known as a ‘randomized controlled feasibility trial’. This involved 105 pregnant women who had a family history of atopy. We assigned the families at random to one of two groups either during pregnancy or shortly after their babies were born, before the baby’s first bath. The groups were called the intervention group and the control group. Families in the intervention group were asked not to bathe their baby more than once a week during the first 6 months and to keep baths short and not too hot. Families in the control group received the standard infant care advice from their maternity units. We wanted to know whether families would be willing to take part in our trial. Most families in the intervention group followed the advice. About 80% bathed their baby once a week or less, compared with 29% in the control group. After following-up with the families, we found that eczema occurred less often in babies who were in the intervention group than in the control group. We did not see any negative effects with reducing how often the infants were bathed. The findings from our test trial suggest that we could conduct a larger trial to investigate whether reducing infant bathing can help prevent eczema.
引用
- Perkin MR, Ussher M, Goldsmith LP, et al. Randomized controlled feasibility trial of an intervention to reduce infant bathing. Br J Dermatol. 2026. PMID: 42359599. doi:10.1093/bjd/ljag248
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。